Lecanemab for Alzheimers Disease: Reduces Amyloid-Beta Plaques But High ARIA Adverse Events (2024 Review)

Lecanemab shows promise in treating Alzheimer’s disease by reducing clinical deterioration and amyloid-beta plaques, but it has significant adverse effects and requires further research for confirmation. Highlights: FDA Approval: The US FDA authorized lecanemab for Alzheimer’s disease treatment in January 2023. Efficacy: Lecanemab significantly reduces clinical deterioration and amyloid-beta plaques in the brain. Adverse Effects: …

Read more

Dangers & Side Effects of Energy Drinks: What Does the Scientific Evidence Say?

Energy drinks are beverages that contain ingredients such as caffeine, taurine, and herbal extracts designed to provide mental and physical stimulation. Their popularity and consumption have grown exponentially in recent years, especially among young people. However, concerns have emerged about potential dangers and side effects. Key facts from a recent systematic review: 96,549 people who …

Read more